Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Grant or award Director acquired 33,847 shares (grant or award)
  2. 8-K Event Material agreement · Regulation FD disclosure
  3. 424B5 Offering Prospectus
  4. 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
  5. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. DEFR14A Other DEFR14A
  9. 8-K Event Material agreement · Regulation FD disclosure
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 480 shares (to pay taxes)
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Executive or director change · Regulation FD disclosure
  16. 4 Grant or award EVP, Business Operations acquired 18,462 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 57,693 shares (grant or award)
  18. 4 Grant or award EVP, Quality & Ethics, and CPL acquired 11,538 shares (grant or award)
  19. 4 Grant or award SVP, Products Business acquired 3,462 shares (grant or award)
  20. 4 Grant or award EVP, Chief Financial Officer acquired 18,462 shares (grant or award)

Page 17 of 87 · 1,733 filings